2019 annual financial data
Voyager Therapeutics 2019 Operating margin
Voyager Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -49.51%.
Operating income was -51,679,000 USD and net income was -40,832,000 USD.
Operating cash flow was 48,666,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 104,391,000 USD
- Operating income
- -51,679,000 USD
- Net income
- -40,832,000 USD
- Operating cash flow
- 48,666,000 USD